Israel Charo
Impact in
- Immunology top 0.02%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immunology and Allergy top 0.05%
- Cell Adhesion Molecules Research
Papers in
- Immunology 100
- Immune cells in cancer 27
- T-cell and B-cell Immunology 26
- Immunotherapy and Immune Responses 22
- Atherosclerosis and Cardiovascular Diseases 19
- Immune Response and Inflammation 18
- Oncology 88
- Chemokine receptors and signaling 80
- Co-authors
- Richard M. Ransohoff (10 shared papers)Jennifa Gosling (12 shared papers)Landin Boring (12 shared papers)Michael D. Cleary (3 shared papers)David R. Phillips (9 shared papers)Wendy Peters (8 shared papers)Chia-Lin Tsou (13 shared papers)Mark B. Taubman (5 shared papers)
- Journals
- The Journal of Immunology (19 papers)Journal of Biological Chemistry (19 papers)Journal of Clinical Investigation (16 papers)The Journal of Experimental Medicine (8 papers)Proceedings of the National Academy of Sciences (7 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Israel Charo
160 papers receiving 28.8k citations
Israel Charo's Hit Papers
Peers
Comparison fields: 5 of 148
- Immunology 14.9k
- Immunology and Allergy 3.6k
- Neurology 2.9k
- Oncology 8.3k
- Virology 1.3k
Countries citing papers authored by Israel Charo
This map shows the geographic impact of Israel Charo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Israel Charo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Israel Charo more than expected).
Fields of papers citing papers by Israel Charo
This network shows the impact of papers produced by Israel Charo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Israel Charo. The network helps show where Israel Charo may publish in the future.
Co-authors
The 25 scholars most cited alongside Israel Charo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Many Roles of Chemokines and Chemokine Receptors in Inflammation Hit paper breakdown → | 2006 | 1987 |
| 2 | Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis Hit paper breakdown → | 1998 | 1608 |
| 3 | International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors Hit paper breakdown → | 2000 | 1477 |
| 4 | CCR2 modulates inflammatory and metabolic effects of high-fat feeding Hit paper breakdown → | 2005 | 1226 |
| 5 | Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. Hit paper breakdown → | 1997 | 908 |
| 6 | Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites Hit paper breakdown → | 2007 | 879 |
| 7 | Langerhans cells renew in the skin throughout life under steady-state conditions Hit paper breakdown → | 2002 | 732 |
| 8 | Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Hit paper breakdown → | 1994 | 627 |
| 9 | Chemokines in the Pathogenesis of Vascular Disease Hit paper breakdown → | 2004 | 616 |
| 10 | MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B Hit paper breakdown → | 1999 | 552 |
| 11 | 2000 | 479 | |
| 12 | 1991 | 473 | |
| 13 | Resolving postoperative neuroinflammation and cognitive decline Hit paper breakdown → | 2011 | 457 |
| 14 | 2010 | 457 | |
| 15 | B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction Hit paper breakdown → | 2013 | 436 |
| 16 | 1991 | 430 | |
| 17 | 1996 | 393 | |
| 18 | 2003 | 387 | |
| 19 | 2011 | 368 | |
| 20 | 2015 | 350 |
About Israel Charo
Israel Charo is a scholar working on Immunology, Oncology, Immunology and Allergy, Molecular Biology and Hematology, having authored 162 papers that have together received 29.4k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (80 papers), Cell Adhesion Molecules Research (33 papers), Immune cells in cancer (27 papers), T-cell and B-cell Immunology (26 papers), Immunotherapy and Immune Responses (22 papers), Atherosclerosis and Cardiovascular Diseases (19 papers), Immune Response and Inflammation (18 papers) and Platelet Disorders and Treatments (15 papers). The work is most often cited by research in Immunology (14.9k citations), Immunology and Allergy (3.6k citations), Neurology (2.9k citations), Oncology (8.3k citations) and Virology (1.3k citations). Israel Charo has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Richard M. Ransohoff, Jennifa Gosling, Landin Boring, Michael D. Cleary, David R. Phillips, Wendy Peters, Chia-Lin Tsou, Mark B. Taubman, Sarah Slaymaker and Christopher A. Haskell. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Journal of Clinical Investigation, The Journal of Experimental Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.